- Home
- MEDP vs ASND Comparison
MEDP vs ASND Comparison
Compare MEDP & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- ASND
- Stock Information
- Founded
- MEDP 1992
- ASND 2006
- Country
- MEDP United States
- ASND Denmark
- Employees
- MEDP N/A
- ASND N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- MEDP Health Care
- ASND Health Care
- Exchange
- MEDP Nasdaq
- ASND Nasdaq
- Market Cap
- MEDP 8.3B
- ASND 9.8B
- IPO Year
- MEDP 2016
- ASND 2015
- Fundamental
- Price
- MEDP $294.90
- ASND $162.84
- Analyst Decision
- MEDP Hold
- ASND Strong Buy
- Analyst Count
- MEDP 10
- ASND 16
- Target Price
- MEDP $343.22
- ASND $213.88
- AVG Volume (30 Days)
- MEDP 333.7K
- ASND 477.8K
- Earning Date
- MEDP 07-21-2025
- ASND 05-01-2025
- Dividend Yield
- MEDP N/A
- ASND N/A
- EPS Growth
- MEDP 33.36
- ASND N/A
- EPS
- MEDP 13.09
- ASND N/A
- Revenue
- MEDP $2,156,580,000.00
- ASND $398,509,511.00
- Revenue This Year
- MEDP $5.59
- ASND $76.03
- Revenue Next Year
- MEDP $3.46
- ASND $74.19
- P/E Ratio
- MEDP $22.53
- ASND N/A
- Revenue Growth
- MEDP 9.87
- ASND 12.06
- 52 Week Low
- MEDP $250.05
- ASND $111.09
- 52 Week High
- MEDP $459.77
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- MEDP 46.73
- ASND 53.99
- Support Level
- MEDP $293.51
- ASND $156.56
- Resistance Level
- MEDP $302.32
- ASND $163.55
- Average True Range (ATR)
- MEDP 9.27
- ASND 6.04
- MACD
- MEDP -0.39
- ASND 0.09
- Stochastic Oscillator
- MEDP 33.56
- ASND 80.88
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.